Iceland vs New Caledonia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Iceland
0 patients
in 2014
New Caledonia
0 patients
in 2021
Iceland rank
141st
New Caledonia rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Iceland
- New Caledonia
How they compare
Iceland currently reports 0 patients against 0 patients in New Caledonia, a difference of 0 patients.
The two have swapped places 3 times across 6 shared years of data; in 2003 it was Iceland ahead.
Iceland ranks 141st and New Caledonia ranks 141st of 183 countries.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iceland | New Caledonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.8 patients | 0.2 patients | 0.6 patients | Iceland |
| 2010s | 0 patients | 0 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Iceland or New Caledonia?
- Iceland, at 0 patients against 0 patients in New Caledonia as of 2014.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Iceland and New Caledonia?
- 0 patients, with Iceland ahead.
- How many years of comparable data are there for Iceland and New Caledonia?
- 6 years are reported by both, from 2003 to 2010.
- How do Iceland and New Caledonia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Iceland ranks 141st and New Caledonia ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.